These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23592361)

  • 1. Possible warfarin resistance due to interaction with ascorbic acid: case report and literature review.
    Sattar A; Willman JE; Kolluri R
    Am J Health Syst Pharm; 2013 May; 70(9):782-6. PubMed ID: 23592361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malabsorption-associated warfarin resistance.
    Sabol BJ; Basa RR; Wilkins CE
    Am J Health Syst Pharm; 2009 Sep; 66(17):1548-53. PubMed ID: 19710438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prednisone on the International Normalized Ratio.
    Stading JA; Chock A; Faulkner MA; Skrabal MZ
    Am J Health Syst Pharm; 2006 Dec; 63(23):2354-6. PubMed ID: 17106008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin and acetaminophen interaction.
    Gebauer MG; Nyfort-Hansen K; Henschke PJ; Gallus AS
    Pharmacotherapy; 2003 Jan; 23(1):109-12. PubMed ID: 12523469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated International Normalized Ratio values in a patient receiving warfarin and ceftaroline.
    Farhat NM; Hutchinson LS; Peters M
    Am J Health Syst Pharm; 2016 Jan; 73(2):56-9. PubMed ID: 26721534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin.
    Moretti LV; Montalvo RO
    Am J Health Syst Pharm; 2009 Dec; 66(23):2123-5. PubMed ID: 19923313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated international normalized ratio associated with concomitant warfarin and erlotinib.
    Thomas KS; Billingsley A; Amarshi N; Nair BA
    Am J Health Syst Pharm; 2010 Sep; 67(17):1426-9. PubMed ID: 20720241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent interaction between telaprevir and warfarin in a patient with chronic hepatitis C viral infection.
    Gatti DC; Cha A
    Am J Health Syst Pharm; 2012 Dec; 69(23):2062-5. PubMed ID: 23172264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
    Parrish RH; Pazdur DE; O'donnell PJ
    Pharmacotherapy; 2006 Nov; 26(11):1650-3. PubMed ID: 17064211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible warfarin interaction with menthol cough drops.
    Kassebaum PJ; Shaw DL; Tomich DJ
    Ann Pharmacother; 2005 Feb; 39(2):365-7. PubMed ID: 15644472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy.
    Sobieraj DM; Wang F; Kirton OC
    Pharmacotherapy; 2008 Dec; 28(12):1537-41. PubMed ID: 19025435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated International Normalized Ratio in a patient concurrently using warfarin and vismodegib.
    Lim S; Houranieh J; Crawford R
    Am J Health Syst Pharm; 2014 Feb; 71(3):200-3. PubMed ID: 24429012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probable interaction between warfarin and marijuana smoking.
    Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
    Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of warfarin anticoagulation associated with chelation therapy.
    Grebe HB; Gregory PJ
    Pharmacotherapy; 2002 Aug; 22(8):1067-9. PubMed ID: 12173793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated international normalized ratio values associated with concomitant use of warfarin and ceftriaxone.
    Clark TR; Burns S
    Am J Health Syst Pharm; 2011 Sep; 68(17):1603-5. PubMed ID: 21856805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.
    Lee R; Wen A; Berube C
    Am J Health Syst Pharm; 2011 May; 68(9):814-7. PubMed ID: 21515865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probable interaction between warfarin and bee pollen.
    Hurren KM; Lewis CL
    Am J Health Syst Pharm; 2010 Dec; 67(23):2034-7. PubMed ID: 21098375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supratherapeutic international normalized ratio due to reduced vitamin K intake secondary to prolonged vomiting in a patient on warfarin.
    Reaves AB; Clarke CJ; Tillman EM
    Ann Pharmacother; 2013 Jun; 47(6):e28. PubMed ID: 23719786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.